RECRUITING

Outcomes Mandate National Integration With Cannabis as Medicine

Talk to us

Conditions

Chronic PainChronic Pain SyndromeChronic Pain Due to InjuryChronic Pain Due to TraumaFibromyalgiaSeizuresHepatitis CCancerCrohn DiseaseHIV/AIDSMultiple SclerosisTraumatic Brain InjurySickle Cell DiseasePost Traumatic Stress DisorderTourette SyndromeUlcerative ColitisGlaucomaEpilepsyInflammatory Bowel DiseasesParkinson DiseaseAmyotrophic Lateral SclerosisChronic Traumatic EncephalopathyAnxietyDepressionInsomniaAutismOpioid-use DisorderBipolar DisorderCovid19SARS-CoV InfectionCOVID-19Corona Virus InfectionCoronavirus

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This will be a multistate, multicenter clinical study to determine the efficacy and safety of medical cannabis for a wide variety of chronic medical conditions.

Official Title

Outcomes Mandate National Integration With Cannabis as Medicine

Quick Facts

Study Start:2018-12-01
Study Completion:2025-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03944447

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:7 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Clinical diagnosis of a Qualifying Condition for Medical Marijuana
  2. * Must be 18 years or older unless they have consent from their parent or legal guardian as defined under state law parameters
  3. * Must be willing to complete online surveys at baseline and the follow up points in this study
  1. * Pregnancy
  2. * Breastfeeding
  3. * Inability to provide informed consent
  4. * Inability to complete study visits or questionnaires
  5. * Active suicidality or psychosis, that could be exacerbated by the administration of cannabis

Contacts and Locations

Study Contact

Dr. Ryan O Lakin, MD JD
CONTACT
419-214-3220
ryan.lakin.md@gmail.com

Principal Investigator

Dr. Ryan O Lakin, MD JD
PRINCIPAL_INVESTIGATOR
OMNI Medical Services Inc

Study Locations (Sites)

OMNI Medical Services
Boca Raton, Florida, 33433
United States
OMNI Medical Services
Bradenton, Florida, 34209
United States
OMNI Medical Services
Fort Lauderdale, Florida, 33308
United States
OMNI Medical Services
Fort Myers, Florida, 34135
United States
OMNI Medical Services
Gainesville, Florida, 36201
United States
OMNI Medical Services
Merritt Island, Florida, 32952
United States
OMNI Medical Services
Miami, Florida, 33137
United States
OMNI Medical Services
Ocoee, Florida, 34761
United States
OMNI Medical Services
Pensacola, Florida, 32505
United States
OMNI Medical Services
Pompano Beach, Florida, 33060
United States
OMNI Medical Services
Tampa, Florida, 33614
United States
OMNI Medical Services
Wesley Chapel, Florida, 33544
United States
OMNI Medical Services
Beechwood, Ohio, 44122
United States
OMNI Medical Services
Bowling Green, Ohio, 43402
United States
OMNI Medical Services
Sandusky, Ohio, 44870
United States
OMNI Medical Services
Toledo, Ohio, 43604
United States
OMNI Medical Services
Toledo, Ohio, 43611
United States

Collaborators and Investigators

Sponsor: OMNI Medical Services, LLC

  • Dr. Ryan O Lakin, MD JD, PRINCIPAL_INVESTIGATOR, OMNI Medical Services Inc

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2018-12-01
Study Completion Date2025-12-31

Study Record Updates

Study Start Date2018-12-01
Study Completion Date2025-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Chronic Pain
  • Chronic Pain Syndrome
  • Chronic Pain Due to Injury
  • Chronic Pain Due to Trauma
  • Fibromyalgia
  • Seizures
  • Hepatitis C
  • Cancer
  • Crohn Disease
  • HIV/AIDS
  • Multiple Sclerosis
  • Traumatic Brain Injury
  • Sickle Cell Disease
  • Post Traumatic Stress Disorder
  • Tourette Syndrome
  • Ulcerative Colitis
  • Glaucoma
  • Epilepsy
  • Inflammatory Bowel Diseases
  • Parkinson Disease
  • Amyotrophic Lateral Sclerosis
  • Chronic Traumatic Encephalopathy
  • Anxiety
  • Depression
  • Insomnia
  • Autism
  • Opioid-use Disorder
  • Bipolar Disorder
  • Covid19
  • SARS-CoV Infection
  • COVID-19
  • Corona Virus Infection
  • Coronavirus